Cargando…
A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects
BACKGROUND: HIV-1 coreceptor tropism testing is used to evaluate eligibility for CCR5 antagonist therapy. However, HIV-1 RNA-based tests are not suitable for virologically suppressed patients, therefore the use of proviral DNA tropism testing has been investigated. We describe a novel proviral DNA-b...
Autores principales: | Brown, Jennifer, Burger, Harold, Weiser, Barbara, Pollard, Richard B, Li, Xiao-Dong, Clancy, Lynell J, Baumann, Russell E, Rogers, Amy A, Hamdan, Hasnah B, Pesano, Rick L, Kagan, Ron M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045881/ https://www.ncbi.nlm.nih.gov/pubmed/24904682 http://dx.doi.org/10.1186/1742-6405-11-14 |
Ejemplares similares
-
Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression
por: Baumann, Russell E, et al.
Publicado: (2015) -
Possible involvement of distinct phylogenetic clusters of HIV-1 variants in the discrepancies between coreceptor tropism predictions based on viral RNA and proviral DNA
por: Kotani, Hiroshi, et al.
Publicado: (2016) -
HIV coreceptor tropism determination and mutational pattern identification
por: Shen, Hui-Shuang, et al.
Publicado: (2016) -
A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients
por: Kagan, Ron M., et al.
Publicado: (2012) -
Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)